Synthetic Progestin Market Growth Report 2021 to 2031
The Synthetic Progestin Market is expected to register a CAGR of 12.8% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Synthetic Progestin Market report covers analysis By Type (Oral Type, Injection Type, and Suspended/Gel Type); End Use (Hospital, Clinic, Pharmacies and Drug Stores, and Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Synthetic Progestin Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Synthetic Progestin Market Segmentation
Type- Oral Type
- Injection Type
- Suspended/Gel Type
- Hospital
- Clinic
- Pharmacies and Drug Stores
Strategic Insights
Synthetic Progestin Market Growth Drivers- Rising Demand for Contraceptive Products: The market size of synthetic progestin grows with its use in hormonal therapies, including contraception and menopausal treatments. The reports in the market cite an increased adoption of combination therapies as one of the key drivers of growth.
- Increased health awareness among women: Increasing awareness of women's reproductive health and the availability of progestin-based solutions augment market trends. Competitive analysis suggests that healthcare campaigns and easy access to medicines have improved the global market.
- Advanced Technologies in Fertility Treatments: Technological developments in drug delivery products, including implants and patches, are driving synthetic progestin use. A PEST analysis identifies these technological innovations as key drivers in forming the growth of the market.
- Development of New Synthetic Progestin Formulations: There is a great use of synthetic progestins in contraceptives, where market statistics indicate a gradual growth based on the government schemes of planning families.
- Increased Adoption of Long-Acting Contraceptives: There is a rising trend toward the use of long-acting reversible contraceptives, including IUDs and implants that often contain synthetic progestins. These methods offer convenience and higher effectiveness and have contributed to a shift in preference from oral contraceptives to more long-term solutions.
- Focus on Non-Oral Delivery Systems: A rising trend in synthetic progestins is the development of delivery forms that are not oral. Some examples include injections, patches, and implants. These methods will help women avoid problems linked with oral contraceptives like gastrointestinal issues or missed doses, and the risk factors will be reduced in this form.
- Expanding Applications in Endometriosis and Menstrual Disorders: Synthetic progestins are used in the treatment of various gynecological conditions, including endometriosis and menstrual disorders. The rising incidence of menopausal disorders is increasing the need for synthetic progestins and thus driving the market outlook. Asia-Pacific is seen as a key growth geography.
- Expanding in Emerging Markets: There is significant growth potential for synthetic progestins in emerging markets, particularly in Asia-Pacific, Latin America, and Africa. Increased healthcare access, rising awareness about family planning, and growing adoption of modern contraceptive methods in these regions are expected to drive the synthetic progestin market in these areas.
- Increasing Focus on Women's Health: With growing awareness of women's health issues and the increasing demand for healthcare services focused on reproductive health, synthetic progestins present a significant opportunity for pharmaceutical companies. The demand for products that address issues like infertility, irregular menstruation, and hormonal imbalance is expected to grow, offering new market avenues.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Synthetic Progestin Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Synthetic Progestin Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Synthetic Progestin Market is estimated to witness a CAGR of 12.8% from 2023 to 2031.
The major factors driving the Market are: Use in hormonal therapies, Awareness of women's health, Advancements in drug delivery
Key future trends in this market are - Growth in Contraceptive Applications, Demand in Hormone Replacement Therapy, Innovation in Drug Delivery Systems
Key companies of this market are: Merck, Teva Generics, Zhejiang Xianju Pharmaceutical, Zhejiang Aisheng Pharmaceutical, Besins Healthcare, Zhejiang Medicine, Virtus Pharmaceuticals, LLC, BionPharma, Pfizer Inc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Synthetic Progestin Market - By Type
1.3.2 Synthetic Progestin Market - By End Use
1.3.3 Synthetic Progestin Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SYNTHETIC PROGESTIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SYNTHETIC PROGESTIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SYNTHETIC PROGESTIN MARKET - GLOBAL MARKET ANALYSIS
6.1. SYNTHETIC PROGESTIN - GLOBAL MARKET OVERVIEW
6.2. SYNTHETIC PROGESTIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. SYNTHETIC PROGESTIN MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ORAL TYPE
7.3.1. Overview
7.3.2. Oral Type Market Forecast and Analysis
7.4. INJECTION TYPE
7.4.1. Overview
7.4.2. Injection Type Market Forecast and Analysis
7.5. SUSPENDED/GEL TYPE
7.5.1. Overview
7.5.2. Suspended/Gel Type Market Forecast and Analysis
8. SYNTHETIC PROGESTIN MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. PHARMACIES AND DRUG STORES
8.5.1. Overview
8.5.2. Pharmacies and Drug Stores Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. SYNTHETIC PROGESTIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Synthetic Progestin Market Overview
9.1.2 North America Synthetic Progestin Market Forecasts and Analysis
9.1.3 North America Synthetic Progestin Market Forecasts and Analysis - By Type
9.1.4 North America Synthetic Progestin Market Forecasts and Analysis - By End Use
9.1.5 North America Synthetic Progestin Market Forecasts and Analysis - By Countries
9.1.5.1 United States Synthetic Progestin Market
9.1.5.1.1 United States Synthetic Progestin Market by Type
9.1.5.1.2 United States Synthetic Progestin Market by End Use
9.1.5.2 Canada Synthetic Progestin Market
9.1.5.2.1 Canada Synthetic Progestin Market by Type
9.1.5.2.2 Canada Synthetic Progestin Market by End Use
9.1.5.3 Mexico Synthetic Progestin Market
9.1.5.3.1 Mexico Synthetic Progestin Market by Type
9.1.5.3.2 Mexico Synthetic Progestin Market by End Use
9.2. EUROPE
9.2.1 Europe Synthetic Progestin Market Overview
9.2.2 Europe Synthetic Progestin Market Forecasts and Analysis
9.2.3 Europe Synthetic Progestin Market Forecasts and Analysis - By Type
9.2.4 Europe Synthetic Progestin Market Forecasts and Analysis - By End Use
9.2.5 Europe Synthetic Progestin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Synthetic Progestin Market
9.2.5.1.1 Germany Synthetic Progestin Market by Type
9.2.5.1.2 Germany Synthetic Progestin Market by End Use
9.2.5.2 France Synthetic Progestin Market
9.2.5.2.1 France Synthetic Progestin Market by Type
9.2.5.2.2 France Synthetic Progestin Market by End Use
9.2.5.3 Italy Synthetic Progestin Market
9.2.5.3.1 Italy Synthetic Progestin Market by Type
9.2.5.3.2 Italy Synthetic Progestin Market by End Use
9.2.5.4 Spain Synthetic Progestin Market
9.2.5.4.1 Spain Synthetic Progestin Market by Type
9.2.5.4.2 Spain Synthetic Progestin Market by End Use
9.2.5.5 United Kingdom Synthetic Progestin Market
9.2.5.5.1 United Kingdom Synthetic Progestin Market by Type
9.2.5.5.2 United Kingdom Synthetic Progestin Market by End Use
9.2.5.6 Rest of Europe Synthetic Progestin Market
9.2.5.6.1 Rest of Europe Synthetic Progestin Market by Type
9.2.5.6.2 Rest of Europe Synthetic Progestin Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Synthetic Progestin Market Overview
9.3.2 Asia-Pacific Synthetic Progestin Market Forecasts and Analysis
9.3.3 Asia-Pacific Synthetic Progestin Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Synthetic Progestin Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Synthetic Progestin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Synthetic Progestin Market
9.3.5.1.1 Australia Synthetic Progestin Market by Type
9.3.5.1.2 Australia Synthetic Progestin Market by End Use
9.3.5.2 China Synthetic Progestin Market
9.3.5.2.1 China Synthetic Progestin Market by Type
9.3.5.2.2 China Synthetic Progestin Market by End Use
9.3.5.3 India Synthetic Progestin Market
9.3.5.3.1 India Synthetic Progestin Market by Type
9.3.5.3.2 India Synthetic Progestin Market by End Use
9.3.5.4 Japan Synthetic Progestin Market
9.3.5.4.1 Japan Synthetic Progestin Market by Type
9.3.5.4.2 Japan Synthetic Progestin Market by End Use
9.3.5.5 South Korea Synthetic Progestin Market
9.3.5.5.1 South Korea Synthetic Progestin Market by Type
9.3.5.5.2 South Korea Synthetic Progestin Market by End Use
9.3.5.6 Rest of Asia-Pacific Synthetic Progestin Market
9.3.5.6.1 Rest of Asia-Pacific Synthetic Progestin Market by Type
9.3.5.6.2 Rest of Asia-Pacific Synthetic Progestin Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Synthetic Progestin Market Overview
9.4.2 Middle East and Africa Synthetic Progestin Market Forecasts and Analysis
9.4.3 Middle East and Africa Synthetic Progestin Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Synthetic Progestin Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Synthetic Progestin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Synthetic Progestin Market
9.4.5.1.1 South Africa Synthetic Progestin Market by Type
9.4.5.1.2 South Africa Synthetic Progestin Market by End Use
9.4.5.2 Saudi Arabia Synthetic Progestin Market
9.4.5.2.1 Saudi Arabia Synthetic Progestin Market by Type
9.4.5.2.2 Saudi Arabia Synthetic Progestin Market by End Use
9.4.5.3 U.A.E Synthetic Progestin Market
9.4.5.3.1 U.A.E Synthetic Progestin Market by Type
9.4.5.3.2 U.A.E Synthetic Progestin Market by End Use
9.4.5.4 Rest of Middle East and Africa Synthetic Progestin Market
9.4.5.4.1 Rest of Middle East and Africa Synthetic Progestin Market by Type
9.4.5.4.2 Rest of Middle East and Africa Synthetic Progestin Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Synthetic Progestin Market Overview
9.5.2 South and Central America Synthetic Progestin Market Forecasts and Analysis
9.5.3 South and Central America Synthetic Progestin Market Forecasts and Analysis - By Type
9.5.4 South and Central America Synthetic Progestin Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Synthetic Progestin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Synthetic Progestin Market
9.5.5.1.1 Brazil Synthetic Progestin Market by Type
9.5.5.1.2 Brazil Synthetic Progestin Market by End Use
9.5.5.2 Argentina Synthetic Progestin Market
9.5.5.2.1 Argentina Synthetic Progestin Market by Type
9.5.5.2.2 Argentina Synthetic Progestin Market by End Use
9.5.5.3 Rest of South and Central America Synthetic Progestin Market
9.5.5.3.1 Rest of South and Central America Synthetic Progestin Market by Type
9.5.5.3.2 Rest of South and Central America Synthetic Progestin Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SYNTHETIC PROGESTIN MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SYNTHETIC PROGESTIN MARKET, KEY COMPANY PROFILES
12.1. MERCK
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. TEVA GENERICS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ZHEJIANG XIANJU PHARMACEUTICAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ZHEJIANG AISHENG PHARMACEUTICAL
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BESINS HEALTHCARE
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ZHEJIANG MEDICINE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. VIRTUS PHARMACEUTICALS, LLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIONPHARMA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GLAXOSMITHKLINE PLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Merck
2. Teva Generics
3. Zhejiang Xianju Pharmaceutical
4. Zhejiang Aisheng Pharmaceutical
5. Besins Healthcare
6. Zhejiang Medicine
7. Virtus Pharmaceuticals, LLC
8. BionPharma
9. Pfizer Inc.
10. GlaxoSmithKline plc
11. Solvay
12. Kaitai Hormone
13. ALLERGAN
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For